Geiseler - Figure 27
Pharmacotherapeutic Approaches to Secretion Management in COPD
References
[1]
Ha EVS, Rogers DF. Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases. Pharmacology 2016;97:84–100.
Ha EVS, Rogers DF. Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases. Pharmacology 2016;97:84–100.